Policy Notices

• Reminder: NIH Policy for Data Management and Sharing effective on January 25, 2023.
  (NOT-OD-23-053)
  National Institutes of Health
  

• OMB Administrative Relief for Recipients Impacted by Hurricanes Fiona and Ian and the Alaska Flood and Landslide
  (NOT-OD-23-065)
  National Institutes of Health
  

General Notices

• Technical Assistance Webinars for RFA-NS-23-012 "Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
  (NOT-NS-23-060)
  National Institute of Neurological Disorders and Stroke
  

• Request for Information (RFI) on Update to NOT-OD-05-034 Guidance on Prompt Reporting of Noncompliances to OLAW
  (NOT-OD-23-063)
  Office of the Director, NIH
  

Notice of Changes to Funding Opportunities

• Notice of NIAMS' Participation in RFA-TR-22-030, "Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)"
  (NOT-AR-23-012)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Early Termination of NOT-DA-23-005, Notice of Special Interest (NOSI): HEAL Initiative: Biospecimen Collection in Pregnancy
  (NOT-DA-23-016)
  National Institute on Drug Abuse
  

• Notice of Receipt Date Change for PAR-21-041 NEI Collaborative Clinical Vision Research: Chair's Grant (UG1-Clinical Trial Required)
  (NOT-EY-23-003)
  National Eye Institute
  

• Notice of Correction to Number of Applications for RFA-HL-24-003 and RFA-HL-24-004 "Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (U24 and R25)"
  (NOT-HL-23-073)
  National Heart, Lung, and Blood Institute
  

• Notice of Correction to the Eligible Organizations, Number of Applications, and Component Type to Use in the Multi-Project Application Instructions for RFA-MD-23-001, "Research Centers in Minority Institutions (RCMI) (U54 Clinical Trial Optional)"
  (NOT-MD-23-006)
  National Institute on Minority Health and Health Disparities
  

• Notice of Early Termination of NOT-OD-23-029 Notice of Special Interest (NOSI): Research on Gender Measurement (Admin Supp Clinical Trial Optional)
  (NOT-OD-23-043)
  Office of Research on Women's Health
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for A Consortium for Gut-Brain Communication in Parkinsons Disease (U01 Clinical Trial Not Allowed)
  (NOT-DK-23-006)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Intent to Publish a Funding Opportunity Announcement for A Consortium for Gut-Brain Communication in Parkinsons Disease (U24 Clinical Trial Not Allowed)
  (NOT-DK-23-007)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required)
  (NOT-MH-23-160)
  National Institute of Mental Health
  

Requests for Proposal

• 2023 NIAID Omnibus Broad Agency Announcement HHS-NIH-NIAID-BAA2023-1
  (NOT-AI-23-025)
  National Institute of Allergy and Infectious Diseases
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Administrative Supplements for NCI Global Oncology Mentored Research
  (NOT-CA-23-038)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Pharmacogenomic Approaches to Enhancing HIV and Substance Use Disorder (SUD) Treatment Strategies, A jump into Precision Medicine.
  (NOT-DA-24-001)
  National Institute on Drug Abuse
  

• Notice of Special Interest (NOSI): Administrative Supplement for NIDCD National Human Ear Resource Network Coordination Center
  (NOT-DC-23-002)
  National Institute on Deafness and Other Communication Disorders
  

• Notice of Special Interest (NOSI): Research on Gender Measurement (Admin Supp Clinical Trial Optional)
  (NOT-OD-23-046)
  Office of Research on Women's Health
  National Cancer Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Minority Health and Health Disparities
  National Library of Medicine
  

Funding Opportunities

• Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
  (PA-23-048)
  National Institutes of Health
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute of Nursing Research
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): May 07, 2026
  
  

• AHRQ Small Research Projects to Advance the Science of Primary Care (R03)
  (PA-23-115)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): June 16, 2023 or Standard dates apply All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed
  (RFA-FD-23-019)
  Food and Drug Administration
  Application Receipt Date(s): April 21, 2023, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
  
  

• Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed
  (RFA-FD-23-027)
  Food and Drug Administration
  Application Receipt Date(s): April 21, 2023, by 11:59 PM Eastern Time